文献速递慢性肾脏病肾血管病与高血压

睡眠时段动态血压是慢性肾脏病的独立预后标志物

Sleep-Time Ambulatory BP Is an Independent Prognostic Marker of CKD.
PubMed 文献 · J Am Soc Nephrol · 2017-04-28

研究前瞻性纳入2763例基线无慢性肾脏病、动态血压从正常到高血压的个体,每年监测48小时动态血压与腕式活动记录。中位随访5.9年间404例发生慢性肾脏病;校正混杂因素后,平均睡眠收缩压每升高1个标准差,慢性肾脏病风险比为1.44(95%CI 1.31–1.56,P<0.001),而诊室血压及清醒或48小时动态血压在校正睡眠血压后预测价值不显著。

要点

  • 平均睡眠收缩压是慢性肾脏病最显著的独立预测因子,每1-SD升高HR 1.44(95%CI 1.31–1.56,P<0.001)。
  • 校正平均睡眠血压后,诊室血压及清醒或48小时动态血压的预测价值不显著。
  • 随访中平均睡眠收缩压每降低1-SD,慢性肾脏病风险降低27%,独立于诊室血压或清醒动态血压变化。

核心结论

  • 睡眠时段血压是慢性肾脏病高度显著的独立预后标志物。
  • 治疗引起的睡眠血压逐渐下降可能是降低慢性肾脏病风险的显著方法,该潜在治疗靶点需要动态血压评估。

研究设计与样本

  • 前瞻性评估2763例基线无慢性肾脏病个体,其中男性1343例、女性1420例,平均±标准差年龄51.5±14.3岁,基线动态血压从正常到高血压。
  • 入组时及此后每年(若基于动态血压调整高血压治疗则更频繁)同时监测48小时血压与体力活动(腕式活动记录),以准确得出个体化平均清醒与睡眠血压。
  • 中位随访5.9年,404例参与者发生慢性肾脏病。

主要发现

  • 在校正年龄、糖尿病、血清肌酐浓度、尿白蛋白浓度、既往心血管事件及高血压治疗时间(醒时 vs 睡前)的Cox比例风险模型中,平均睡眠收缩压是慢性肾脏病最显著的预测因子(每1-SD升高:HR 1.44,95%CI 1.31–1.56,P<0.001)。
  • 校正平均睡眠血压后,平均诊室血压及平均清醒或48小时动态血压的预测价值不显著。
  • 随访期间血压变化分析显示,平均睡眠收缩压每降低1-SD,慢性肾脏病风险降低27%,独立于平均诊室血压或清醒动态血压的变化。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The prognostic value of clinic and ambulatory BP in predicting incident CKD and whether CKD risk reduction associates with progressive treatment-induced decrease of clinic, awake, or asleep BP are unknown. We prospectively evaluated 2763 individuals without CKD, 1343 men and 1420 women (mean±SD age: 51.5±14.3 years old), with baseline ambulatory BP ranging from normotension to hypertension. On recruitment and annually thereafter (more frequently if hypertension treatment was adjusted on the basis of ambulatory BP), we simultaneously monitored BP and physical activity (wrist actigraphy) for 48 hours to accurately derive individualized mean awake and asleep BP. During a median 5.9-year follow-up, 404 participants developed CKD. Mean asleep systolic BP was the most significant predictor of CKD in a Cox proportional hazard model adjusted for age, diabetes, serum creatinine concentration, urinary albumin concentration, previous cardiovascular event, and hypertension treatment time (on awakening versus at bedtime; per 1-SD elevation: hazard ratio, 1.44; 95% confidence interval, 1.31 to 1.56; P<0.001). The predictive values of mean clinic BP and mean awake or 48-hour ambulatory BP was not significant when corrected by mean asleep BP. Analyses of BP changes during follow-up revealed 27% reduction in the risk of CKD per 1-SD decrease in mean asleep systolic BP, independent of changes in mean clinic BP or awake ambulatory BP. In conclusion, sleep-time BP is a highly significant independent prognostic marker for CKD. Furthermore, progressive treatment-induced decrease of asleep BP, a potential therapeutic target requiring ambulatory BP evaluation, might be a significant method for reducing CKD risk.

来源:J Am Soc Nephrol,查看原文。版权归原作者所有。

引用

  1. Hermida RC, Ayala DE, Mojón A, et al. Sleep-Time Ambulatory BP Is an Independent Prognostic Marker of CKD. J Am Soc Nephrol. 2017. PMID: 28455314. doi:10.1681/ASN.2016111186

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。